Billing Code: 4163-18-P

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

PACT- Providing AIDS Care and Treatment in the Democratic Republic of Congo under the President's Emergency Plan for AIDS Relief (PEPFAR)

Announcement Type: New

Funding Opportunity Number: CDC-RFA-PS08-811 

Catalog of Federal Domestic Assistance Number: 93.067

Key Dates:

Application Deadline: June 23, 2008

 

I. Funding Opportunity Description

Authority: This program is authorized under Public Law 108-25 (United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003) [22 U.S.C. 7601).

 

Background:

President Bush's Emergency Plan for AIDS Relief has called for immediate, comprehensive and evidence-based action to turn the tide of global HIV/AIDS. The initiative aims to treat more than two million HIV-infected people with effective combination antiretroviral therapy (ART) by 2008; care for ten million HIV-infected and affected persons, including those orphaned by HIV/AIDS, by 2008; and prevent seven million infections by 2010, with a focus on 15 priority countries, including 12 in sub-Saharan Africa.  The Five-Year Strategy for the Emergency Plan is available at the following Internet address:  http://www.state.gov/s/gac/plan/c11652.htm

 

Purpose:

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan.

 

HHS/CDC focuses on two or three major program areas in each country.  Goals and priorities include the following:

 

 

The purpose of this announcement is to improve services and client health outcomes by strengthening the service capacity of selected sites in the Kinshasa, Democratic Republic of Congo (DRC), health facilities network that provides family based HIV prevention, care and treatment. The health facilities network consists of 34 maternities providing prevention of mother-to-child tranmission (PMTCT) services, 14 TB clinics, one comprehensive care clinic and one pediatric hospital providing care and treatment services in the capital city of Kinshasa. Continuum of care services include:  PMTCT; post-birth monitoring and care of HIV-positive (HIV+) women and their newborns whose status has yet to be determined; TB/HIV services; family-based HIV treatment services including diagnosis, care, antiretroviral and psycho-social support; and community-based psycho-social support.

 

In addition, this award will support public health evaluations designed to gather quality data to make evidenced-based program and policy decisions. Accurate, complete and timely data will provide critical information to Ministry of Health programs such as the National AIDS Control Program, the National TB Control Program, and the National Blood Safety Control Program. Financial support of this funding opportunity will provide technical services to conduct public health evaluations that identify access barriers, inefficiencies in delivering comprehensive continuum of HIV services and strengthen intervention data collection that may be used for problem identification and finding practical, low cost solutions. The award will also provide training opportunities for HIV partners in all program areas with an emphasis on hands-on, short-term residences .

 

The recipient of these funds will produce an annual operational plan, which the U.S. Government Emergency Plan team in DRC will review as part of the annual Country Operational Plan review-and-approval process.  HHS/CDC, under the guidance of the U.S. Global AIDS Coordinator, will approve funds for activities on an annual basis, based on documented performance towards achieving Emergency Plan goals and objectives and the availability of funds.

 

Measurable outcomes of the program will be in alignment with the following performance goal(s) for the Emergency Plan:

Assistance provided under this funding opportunity announcement targets the

following goals:

  1. Reduce morbidity and mortality associated with mother-to-child transmission of HIV through the integration of PMTCT services in select maternities in Kinshasa;
  2. Decrease the burden of TB in HIV+ individuals and to improve TB diagnostic capacity by strengthening laboratory services and quality control;
  3. Strengthen a sustainable reproducible model of programmatic, comprehensive, evidence-based family centered HIV care, support and treatment services to HIV+ mothers and their newborns, to former TB patients and to first-line family members of these individuals;
  4. Development of a subset of program indicators that measure the impact of family-based HIV services on the family (healthy parents, healthy children) and program activities that promote the provision of services at the health facility and in the community (effective referral systems, home visits, palliative home care assistance, increasing adherence rates and decreasing drop-out rates);
  5. Improve the health outcomes of HIV+ children in Kinshasa through the provision of comprehensive medical care including no-cost ART and psychosocial support to HIV+ children and their first-line relatives;
  6. Conduct targeted public health evaluations that provide information for changes in critical policy statements or program regulations for health facilities in the Kinshasa network, for the national programs and for HIV partners participating in the national HIV response;
  7. Formalize information sharing and exchange on HIV medical services and management of these services and collaborate with national experts in the preparation, submission and presentation of the DRC experience in delivering HIV-related diagnosis, care and treatment;
  8. Establish an exit strategy to assure continuation of services after the end of this funding opportunity final budget cycle.

 

Applicants should use the Emergency Plan General Indicators when creating measurable outcomes.  The guide can be found on https://www.pepfar.net. 

1.      Preventing Mother-to-Child Transmission (PMTCT)

a.       Number of service outlets providing the minimum package of PMTCT services according to national and international standards:

40 service outlets providing minimum package of PMTCT services

b.      Number of pregnant women who receive HIV counseling and testing for PMTCT and receive their test results:

226,000 pregnant women who receive HIV counseling and testing for PMTCT and receive their test results

c.       Number of HIV-infected pregnant women who receive antiretroviral (ARV) prophylaxis for PMTCT in a PMTCT setting:

4,000 HIV-infected women who receive ARV prophylaxis in a PMTCT setting

d.      Number of health workers trained in the provision of PMTCT services according to national and international standards:

830 health workers trained

e.       Number of HIV-positive pregnant or lactating women receiving food and nutritional supplementation in a PMTCT setting:

811 HIV-positive pregnant or lactating women receiving food or nutritional support in PMTCT setting

 

2.      Counseling and Testing

a.       Number of service outlets providing counseling and testing according to national and international standards:

58 service outlets providing counseling and testing according to national and international standards

b.      Number of individuals who receive counseling and testing for HIV and receive their results (including TB):

83,000 individuals who receive counseling and testing for HIV and receive their results

·        62,250 Males

·        20,750 Females

c.       Number of individuals trained in counseling and testing according to national and international standards:

320 individuals trained in counseling and testing according to national and international standards

d.      Number of individuals who receive counseling and testing for HIV and receive their test results (excluding TB):

59,000 individuals who receive counseling and testing for HIV and receive their test results

·        44,250 Males

·        14,750 Females

 

3.      Palliative Care (Basic Health Care)

a.       Total number of service outlets providing HIV-related palliative care (including TB/HIV):

58 service outlets providing HIV-related palliative care (including TB/HIV)

b.      Total number of individuals provided with HIV-related palliative care (including TB/HIV):

(1)   14,000 individuals provided with HIV-related palliative care (including TB/HIV)

·        5,600 Males

·        8,400 Females

c.       Total number of individuals trained to provide HIV-related palliative care (including TB/HIV):

300 individuals trained to provide HIV-related palliative care (including TB/HIV)

d.      Total number of services outlets providing HIV-related palliative care (excluding TB/HIV):

44 service outlets providing HIV-related palliative care (excluding TB/HIV)

e.       Total number of individuals provided with HIV-related palliative care (excluding TB/HIV):

9,700 of individuals provided with HIV-related palliative care (excluding TB/HIV)

·        3,880 Males

·        5,820 Females

f.        Total number of individuals trained to provide HIV palliative care (excluding TB/HIV):

240 individuals trained to provide HIV palliative care (excluding TB/HIV)

 

4.      Palliative Care (TB/HIV)

a.       Number of service outlets providing treatment for TB to HIV-infected individuals (diagnosed or presumed) in a palliative care setting

One(1) service outlet providing clinical prophylaxis and/or treatment for TB to HIV-infected individuals (diagnosed or presumed) in a palliative care setting

b.      Number of HIV-infected clients attending HIV care/treatment services that are receiving treatment for TB disease:

500 HIV-infected clients attending HIV care/treatment services that are receiving treatment for TB disease

·        225 Males

·        275 Females

c.       Number of individuals trained to provide treatment for TB to HIV-infected individuals (diagnosed or presumed):

15 individuals trained to provide treatment for TB to HIV-infected individuals (diagnosed or presumed)

d.      Number of registered TB patients who received HIV counseling, testing, and their test results at a U.S. Government(USG)-supported TB service outlet:

25,000 registered TB patients who received HIV counseling , testing, and their test results at a USG-supported TB service outlet

·        10,000 Males

·        15,000 Females

 

5.      Orphans and Vulnerable Children (OVC)

a.       Number of OVC served by OVC programs:

2,780 OVC served by OVC programs

b.      Number of providers/caregivers trained in caring for OVC:

39 providers/caregivers trained in caring for OVC

c.       Number of OVC receiving food and nutritional supplementation through OVC programs:

1,940 OVC receiving food and nutritional supplementation through OVC programs

 

6.      HIV/AIDS Treatment/ARV Services

a.       Number of service outlets providing ART:

18 service outlets providing ART

b.      Number of individuals newly initiating ART during the reporting period:

5,000 individuals newly initiating antiretroviral therapy during the reporting period

·        1,000 Males (0-14)

·        850 Males (15+)

·        1,100 Females (0-14)

·        1,650 Females (15+)

·        400 Pregnant females (all ages)

c.       Number of individuals who receive ART by the end of the reporting period:

5,500 individuals who receive ART by the end of the reporting period

·        1,100 Males (0-14)

·        935 Males (15+)

·        1,210 Females (0-14)

·        1,815 Females (15+)

·        440 Pregnant females (all ages)

a.       Number of individuals receiving antiretroviral therapy at the end of the reporting period:

5,000 individuals receiving ART at the end of the reporting period

·        1,000 Males (0-14)

·        850 Males (15+)

·        1,100 Females (0-14)

·        1,650 Females (15+)

·        400 Pregnant females (all ages)

c.       Number of health workers trained to deliver ART services, according to national and/or international standards:

200 health workers trained to deliver ART services, according to national and/or international standards

d.      Number of individuals receiving ART with evidence of severe malnutrition receiving food and nutritional supplementation during the reporting period:

350 individuals receiving ART with evidence of severe malnutrition receiving food and nutritional supplementation

 

7.      Laboratory Infrastructure

a.       Number of laboratories with the capacity to perform (1) HIV tests and (2) CD4 tests and/or lymphocyte tests:

58 laboratories

b.      Number of individuals trained in the provision of laboratory-related activities:

59 individuals trained in the provision of lab-related activities

c.       Number of tests performed at U.S.Government -supported laboratories during the reporting period:  (1) HIV testing, (2) TB diagnostics, (3) syphilis testing, and (4) HIV disease monitoring:

Number of tests performed at U.S. Government-supported laboratories during the reporting period for (1) HIV testing = 412,641, (2) TB diagnostics = 28,993,

(3) Syphilis testing = 276,124, and (4) HIV disease monitoring = 11,118

 

8.      Strategic Information

a.       Number of local organizations provided with technical assistance for strategic information activities (monitoring and evaluation [M&E], surveillance and/or Health Management Information Systems [HMIS])

18 local organizations provided with technical assistance for strategic information activities (M&E, surveillance and/or HMIS)

b.      Number of individuals trained in strategic information (includes M&E, surveillance and/or HMIS)

160 individuals trained in strategic information (includes M&E, surveillance and/or HMIS)

 

9.      Other/ Policy Development and System Strengthening

a.       Number of local organizations provided with technical assistance for HIV-related policy development

3 local organizations provided with technical assistance for HIV-related policy development

b.      Number of local organizations provided with technical assistance for HIV-related institutional capacity building

18 local organizations provided with technical assistance for HIV-related institutional capacity building

c.       Number of individuals trained in HIV-related policy development

9 individuals trained in HIV-related policy development

d.      Number of individuals trained in HIV-related institutional capacity building

65 individuals trained in HIV-related institutional capacity building

e.       Number of individuals trained in HIV-related stigma and discrimination reduction

420 individuals trained in HIV-related stigma and discrimination reduction

f.        Number of individuals trained in HIV-related community mobilization for prevention, care and/or treatment

420 individuals trained in HIV-related community mobilization for prevention, care and/or treatment

 

10.  Family based care indicators

Applicant will propose and develop program indicators (such as immunization coverage, successful referrals) that will measure the impact of this approach to deliver an integrated, comprehensive continuum of care services.

 

This announcement is intended for non-research activities supported by the Centers for Disease Control and Prevention within HHS (HHS/CDC).  If research is proposed, the application will not be reviewed.  For the definition of research, please see the CDC Web site at the following Internet address:  http://www.cdc.gov/od/science/regs/hrpp/researchDefinition.htm.

 

Activities:

The recipient of these funds is responsible for activities in multiple program areas designed to target underserved populations in the Democratic Republic of Congo (DRC).  Either the awardee will implement activities directly or will implement them through its subgrantees and/or subcontractors; the awardee will retain overall financial and programmatic management under the oversight of HHS/CDC and the strategic direction of the Office of the U.S. Global AIDS Coordinator. The awardee must show a measurable progressive reinforcement of the capacity of indigenous organizations and local communities to respond to the national HIV epidemic, as well as progress towards the sustainability of activities.

 

Applicants should describe activities in detail that reflect the policies and goals outlined in the Five-Year Strategy for the President’s Emergency Plan.

 

The grantee will produce an annual operational plan, which the U.S. Government Emergency Plan team on the ground in DRC will review as part of the annual Emergency Plan for AIDS Relief Country Operational Plan review-and-approval process, managed by the Office of the U.S. Global AIDS Coordinator.  The grantee may work on some of the activities listed below in the first year and in subsequent years, and then progressively add others from the list to achieve all of the Emergency Plan performance goals, as cited in the previous section.  HHS/CDC, under the guidance of the U.S. Global AIDS Coordinator, will approve funds for activities on an annual basis, based on documented performance toward achieving Emergency Plan goals, as part of the annual Emergency Plan for AIDS Relief Country Operational Plan review-and-approval process.

 

Applicants should describe activities highlighted below in detail to reflect the policies and goals outlined in PEPFAR and the U.S.Government (USG)/DRC Mission Five Year HIV Strategic Plan.  Applicant will focus on the following activities:

  1. Improving comprehensive PMTCT services to increase uptake of pregnant women seeking antenatal care (ANC) services, to increase uptake of pregnant women accepting HIV counseling and testing, to increase the number of women delivering at a PMTCT maternity facilities who receive PMTCT services (either as an ANC client or first time visit at delivery)
  2. Increasing use of counseling and testing services given to partners of pregnant women, newborns of HIV+ women, TB patients, severely ill or chronically ill children and first line family members through multiple methods including community-based educational efforts.
  3. Increasing use of palliative care services for HIV+ individuals including women who recently delivered in PMTCT maternity facilities, their newborns and first line family members.
  4. Increasing use of HIV/TB co-infection services for clients including palliative care and treatment when eligibility is met.
  5. Increasing use of ART treatment for HIV+ families (one or more first line family members) including psychosocial support.
  6. Improving the referral system for HIV+ individuals (partners, mothers, newborns and other first line relatives) to assure continued services for disease monitoring, early infant diagnosis, palliative care and, when appropriate, ART.
  7. Improve the capacity of health facilities staff to adequately respond to increases in HIV services uptake through trainings, workshops and supervision to assure increased numbers of clients, adequate supplies of pharmaceuticals, laboratory supplies and other medical products through stock management and forecasting needs, maintain administrative/managerial records regarding services provided (M&E), personnel records including trainings conducted (M&E), and procurement records. These activities are important elements of a successful exit strategy that will assure the sustainability of HIV services after the end of the Cooperative Agreement.
  8. Improving recordkeeping of HIV services delivered (HMIS) which provides information on the number of clients receiving services by age group and gender; enable the identification of viable targets for out-years; enable problem identification regarding uptake rates some of which may be the subject of public health evaluations to improve services; and enable the establishment of national gold standards for prevention, care and treatment services delivered in health facilities.
  9. Conduct public health evaluations that identify access barriers or inefficiencies in delivering comprehensive continuum of HIV services. Public health evaluations should address practical solutions to problems.  Examples of previous evaluations include:  assessing preferred methods of assent and disclosure of HIV status to children; evaluating different methods of providing voluntary counseling counseling and testing (VCT) services for TB patients; and weighing the benefits of psychological support groups for TB/HIV co-infected individuals.

10.        In collaboration with national programs, HIV clinical experts and public health professionals facilitate information sharing and exchange on HIV medical services and management of these services via such activities as a web-based clinical “hotline,” mentorships, bulletins, national workshops, (e.g. journées de réflexion or “lessons learned” and sharing experiences and findings from activities carried out), and trainings as well as regularly scheduled public health journal discussions and grand rounds on diagnosis, care and treatment.  Targeted audiences include clinicians, lab technicians, public health experts, HIV partners, social workers and community based organizations providing HIV prevention and psycho-social services 

11.        In collaboration with engaging partners responsible for the overall administration of participating health facilities and with the Ministry of Health, establish an exit strategy to assure continuation of services after the end of this funding opportunity final budget cycle. Exit strategy should address, at minimum, continued pharmaceutical and other medical supplies procurement, activity reporting to national programs within the Ministry of Health, and supervision of activities by national programs.

Administration

The selected applicant for this funding must comply with all HHS/CDC management requirements for meeting participation and progress and financial reporting for this cooperative agreement (See HHS/CDC Activities and Reporting sections below for details), and comply with all policy directives established by the Office of the U.S. Global AIDS Coordinator.

 

In a cooperative agreement, HHS/CDC staff are substantially involved in the program activities, above and beyond routine grant-monitoring. 

HHS/CDC Activities for this program are as follows:

1.      Organize an orientation meeting with the grantee for a briefing on applicable U.S. Government, HHS/CDC, and Emergency Plan expectations, regulations and key management requirements, as well as report formats and contents.  The orientation could include meetings with staff from HHS agencies and the Office of the U.S. Global AIDS Coordinator.

2.      Review and approve the process used by the grantee to select key personnel and/or post-award subcontractors and/or subgrantees to be involved in the activities performed under this agreement, as part of the Emergency Plan for AIDS Relief Country Operational Plan review and approval process, managed by the Office of the U.S. Global AIDS Coordinator.

3.      Review and approve the grantee’s annual work plan and detailed budget, as part of the Emergency Plan for AIDS Relief Country Operational Plan review-and-approval process, managed by the Office of the U.S. Global AIDS Coordinator.

4.      Review and approve the grantee’s monitoring and evaluation plan, including for compliance with the strategic-information guidance established by the Office of the U.S. Global AIDS Coordinator. 

5.      Meet on a monthly basis with the grantee to assess monthly expenditures in relation to approved work plan and modify plans, as necessary.

6.      Meet on a quarterly basis with the grantee to assess quarterly technical and financial progress reports and modify plans as necessary.

7.      Meet on an annual basis with the grantee to review annual progress report for each U.S. Government Fiscal Year, and to review annual work plans and budgets for subsequent year, as part of the Emergency Plan for AIDS Relief review and approval process for Country Operational Plans, managed by the Office of the U.S. Global AIDS Coordinator.

8.      Provide technical assistance, as mutually agreed upon, and revise annually during validation of the first and subsequent annual work plans.  This could include expert technical assistance and targeted training activities in specialized areas, such as strategic information, project management, confidential counseling and testing, palliative care, treatment literacy, and adult-learning techniques. 

9.      Provide in-country administrative support to help grantee meet U.S. Government financial and reporting requirements approved by the Office of Management and Budget (OMB) under 0920-0428 (Public Health Service Form 5161).

10.  Collaborate with the awardee on designing and implementing the activities listed above, including, but not limited to the provision of technical assistance to develop program activities, data management and analysis, quality assurance, the presentation and possibly publication of program results and findings, and the management and tracking of finances.

11.  Provide consultation and scientific and technical assistance based on appropriate, HHS/CDC and Office of the U.S. Global AIDS Coordinator documents to promote the use of best practices known at the time.

12.  Assist the recipient in developing and implementing quality-assurance criteria and procedures.

13.  Facilitate in-country planning and review meetings for technical assistance activities       

 

Please note: Either HHS staff or staff from organizations that have successfully competed for funding under a separate HHS contract, cooperative agreement or grant will provide technical assistance and training.

 

II. Award Information

Type of Award: Cooperative Agreement

HHS/CDC involvement in this program appears in the Activities Section above.

Award Mechanism: U2G

Fiscal Year Funds: 2008

Approximate Current Fiscal Year Funding: $1,800,000

Approximate Total Project Period Funding: $9,000,000 (This amount is an estimate, and is subject to availability of funds.) 

Approximate Number of Awards: 1

Approximate Average Award: $1,800,000 (This amount is for the first 12-month budget period, and includes direct costs (and indirect costs in the case of domestic grantees.) )

Floor of Individual Award Range: $1,300,000

Ceiling of Individual Award Range: $1,800,000 (This ceiling is for the first 12-month budget period.)

Anticipated Award Date:   September 30, 2008

Budget Period Length: 12 Months

Project Period Length: 5 Years

Throughout the project period, HHS/CDC’s commitment to continuation of awards will be conditioned on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the U.S. Government, through the Emergency Plan for AIDS Relief review and approval process for Country Operational Plans, managed by the Office of the U.S. Global AIDS Coordinator.

 

III. Eligibility Information

III.1. Eligible applicants

Eligible applicants that can apply for this funding opportunity appear below:

  • Public, non-profit organizations;
  • Private, non-profit organizations;
  • For-profit organizations;
  • Small, minority, and women-owned businesses;
  • Universities;
  • Colleges;
  • Research institutions;
  • Hospitals;
  • Community-based organizations;
  • Faith-based organizations;
  • Federally recognized Indian tribal Governments;
  • Indian tribes;
  • Indian tribal organizations;
  • U.S. State and local Governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau);
  • Political subdivisions of U.S. States (in consultation with States);

A Bona Fide Agent is an agency/organization identified by a state as eligible to submit an application under the State's eligibility in lieu of a State application.  If applying as a bona fide agent of a State or local Government, a letter from the State or local Government as documentation of the status is required.  Place this documentation behind the first page of the application form.

 

III.2. Cost-Sharing or Matching

 

Matching funds are not required for this program. If applicants receive funding from other sources to underwrite the same or similar activities, or anticipate receiving such funding in the next 12 months, they must detail how the disparate streams of financing complement each other.

 

III.3. Other

If a funding amount greater than the ceiling of the award rangeis requested, HHS/CDC will consider the  application non-responsive, and it will not be entered into the review process. The applicant will be notified that the application did not meet the submission requirements.

 

Special Requirements:

If the application is incomplete or non-responsive to the special requirements listed in this section, it will not enter into the review process.  The applicant will be notified the application did not meet submission requirements.

  • Late applications will be considered non-responsive.  See section “IV.3.  Submission Dates and Times” for more information on deadlines.
  • Note: Title 2 of the United States Code Section 1611 states that an organization described in Section 501(c)(4) of the Internal Revenue Code that engages in lobbying activities is not eligible to receive Federal funds constituting a grant, loan, or an award.

 

IV. Application and Submission Information

IV.1. Address to Request Application Package

To apply for this funding opportunity use application form PHS 5161-1.

 

Electronic Submission:

HHS/CDC strongly encourages applicants to submit applications electronically by using the forms and instructions posted for this announcement on www.Grants.gov, the official U.S. Government agency-wide E-grant Web site.  Only applicants who apply on-line may forego submitting paper copies of all application forms.

 

Registering an applicant’s organization through www.Grants.gov is the first step in submitting applications online. Registration information is located in the “Get Registered” screen of www.Grants.gov.  While application submission through www.Grants.gov is optional, HHS/CDC strongly encourages using this online tool.

Key tips for Registration on Grants.gov:

  • Please visit www.Grants.gov at least 30 days prior to filing an application to become familiar with the registration and submission processes.
  • The one-time registration process will take three to five days to complete.
  • Only the person who registers the organization on grants.gov can submit the application.  This is important to remember if the person who originally registered an organization on grants.gov is no longer working for that particular organization.
  • HHS/CDC suggests submitting electronic applications prior to the closing date so if difficulties are encountered, a hard copy of the application can be submitted prior to the deadline.

 

For Foreign Organizations, the next step would be to obtain a NATO Commercial and Governmental Entity (NCAGE) Code to complete the Grants.gov registration.  Instructions for obtaining an NCAGE Code may be found at http://www.cdc.gov/od/pgo/funding/NATO_Commercial_and_Governmental_Entity_12-18-06.doc.

 

If technical difficulties are encountered in Grants.gov, customer service may be reached by e-mail at support@grants.gov, or by phone 1-800-518-4726 (1-800-518-GRANTS).  The Customer Support Center is open from 7:00 a.m. to 9:00 p.m. Eastern Standard Time, Monday through Friday. 

 

Paper Submission:

Application forms and instructions are available on the HHS/CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm.

 

If access to the Internet is not available, or if there is difficulty in accessing the forms on-line, contact the HHS/CDC Procurement and Grants Office Technical Information Management Section (PGO-TIM) staff at 770-488-2700, and the application forms can be mailed.

 

IV.2. Content and Form of Submission

Application:

 

A Project Abstract must be submitted with the application forms.  All electronic project abstracts must be uploaded in a PDF file format when submitting via Grants.gov.  The abstract must be submitted in the following format, if submitting a paper application:

  • Maximum of 2-3 paragraphs;
  • Font size: 12 point unreduced, Times New Roman;
  • Single spaced;
  • Paper size: 8.5 by 11 inches (preferred), or generally accepted paper size;
  • Page margin size: One inch.

The Project Abstract must contain a summary of the proposed activity suitable for dissemination to the public.  It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed.  It should be informative to other persons working in the same or related fields and insofar as possible understandable to a technically literate lay reader.  This Abstract must not include any proprietary/confidential information. 

 

A project narrative must be submitted with the application forms.  All electronic narratives must be uploaded in a PDF file format when submitting via Grants.gov.  The narrative must be submitted in the following format, if submitting a paper application:

  • Maximum number of pages: 25 (If the narrative exceeds the page limit, the first pages that are within the page limit will be reviewed.);
  • Font size:  12-point, unreduced;
  • Double-spaced;
  • Paper size: 8.5 by 11 inches (preferred), or generally accepted paper size;
  • Page-margin size: One-inch;
  • Number all pages of the application sequentially from page one (Application Face Page) to the end of the application, including charts, figures, tables, and appendices;
  • Print only on one side of each page; and
  • Held together only by rubber bands or metal clips, not bound in any other way.

 

The narrative should address activities the applicant will conduct over the entire project period, and must include the following items, in the order listed:

  • Project Context and Background (Understanding and Need):  Describe the background and justify the need for the proposed project.  Describe the current infrastructure system; targeted geographical area(s), if applicable; and identified gaps or shortcomings of the current health systems and AIDS-control projects in Democratic Republic of Congo;
  • Project Strategy - Description and Methodologies:  Present a detailed operational plan for initiating and conducting the project.  Clearly describe the applicant’s technical approach/methods for implementing the proposed project.  Describe the existence of or plans to establish partnerships necessary to implement the project.  Describe linkages, if appropriate, with programs funded by the U.S. Agency for International Development;
  • Project Goals and Objectives:  Describe the overall goals of the project, and specific objectives that are measurable and time-phased, consistent with the objectives and numerical targets of the President’s Emergency Plan and for this Cooperative Agreement program as provided in the “Purpose” Section at the beginning of this Announcement;
  • Project Outputs:  Be sure to address each of the program objectives listed in the “Purpose” Section of this Announcement.  Measures must be specific, objective and quantitative so as to provide meaningful outcome evaluation;
  • Project Contribution to the Goals and Objectives of the President’s Emergency Plan for AIDS Relief:  Provide specific measures of effectiveness to demonstrate accomplishment of the objectives of this program; 
  • Work Plan and Description of Project Components and Activities:  Be sure to address each of the specific tasks listed in the Activities section of this Announcement.  Clearly identify specific assigned responsibilities for all key professional personnel; 
  • Performance Measures:  Measures must be specific, objective and quantitative;
  • Timeline (e.g., GANNT Chart); and
  • Management of Project Funds and Reporting.

 

Additional information may be included in the appendices.  The appendices will not count toward the narrative page limit.  This additional information includes the following:

  • Project Budget and Justification:

With staffing breakdown and justification, provide a

line-item budget and a narrative with justification for all requested costs. Be sure to include, if any, in-kind support or other contributions provided by the national Government and its donors as part of the total project, but for which you are not requesting funding.

 

Budgets must be consistent with the purpose, objectives of the Emergency Plan and the program activities listed in this announcement and must include the following:

o       Line-item breakdown and justification for all personnel, i.e., name, position title, annual salary, percentage of time and effort, and amount requested.

For each contract, list the following: (1) name of proposed contractor; (2) breakdown and justification for estimated costs; (3) description and scope of activities the contractor will perform; (4) period of performance; (5) method of contractor selection (e.g., competitive solicitation); and (6) methods of accountability.  Applicants should, to the greatest extent possible, employ transparent and open competitive processes to choose contractors; 

  • Curricula vitae of current staff who will work on the activity;
  • Job descriptions of proposed key positions to be created for the activity;
  • Applicant’s Corporate Capability Statement;
  • Letters of Support; and
  • Evidence of Legal Organizational Structure.

 

The agency or organization is required to have a Dun and Bradstreet Data Universal Numbering System (DUNS) number to apply for a grant or cooperative agreement from the Federal government.  The DUNS number is a nine-digit identification number, which uniquely identifies business entities.  Obtaining a DUNS number is easy and there is no charge.  To obtain a DUNS number, access the Dun and Bradstreet website or call 1-866-705-5711. 

 

Additional requirements that could require submission of additional documentation with the application appear in Section “VI.2.  Administrative and National Policy Requirements.”

 

IV.3. Submission Dates and Times

Application Deadline Date: June 23, 2008

 

Explanation of Deadlines: The HHS/CDC Procurement and Grants Office must receive applications by 4:00 p.m. Eastern Time on the deadline date.

 

Electronic Submission: 

HHS/CDC will consider applications completed on-line through Grants.gov as formally submitted when the applicant organization’s Authorizing Official electronically submits the application to www.grants.gov.  The application will be electronically time/date stamped, which will serve as receipt of submission.  Applicants will receive an e-mail notice of receipt when HHS/CDC receives the application.

 

HHS/CDC will consider electronic applications as having met the deadline if the applicant organization’s Authorizing Official has submitted the application electronically to Grants.gov on or before the deadline date and time.

 

Paper Submission:

If submittal of an application is by the United States Postal Service or commercial delivery service, the applicant must ensure the carrier will be able to guarantee delivery by the closing date and time.  The applicant will have the opportunity to submit documentation of the carrier’s guarantee if HHS/CDC receives the submission after the closing date due to (1) carrier error, when the carrier accepted the package with a guarantee for delivery by the closing date and time; or (2) significant weather delays or natural disasters.  If the documentation verifies a carrier problem, HHS/CDC will consider the submission as having been received by the deadline. 

 

If a hard-copy application is submitted, HHS/CDC will not notify the applicant upon receipt of the submission.  If questions arise on the receipt of the application, the applicant should first contact the carrier.  If there are still questions about application delivery, contact the HHS/CDC staff at (770) 488-2700.  Applicants should wait two to three days after the submission deadline before calling.  This will allow time for HHS/CDC to process and log submissions.

 

This announcement is the definitive guide on application content, submission address, and deadline.  It supersedes information provided in the application instructions.  If the application submission does not meet the deadline above, it will not be eligible for review.  The application face page will be returned by HHS/CDC with a written explanation of the reason for non-acceptance.  The applicant will be notified the  application did not meet the submission requirements.

 

IV.4. Intergovernmental Review of Applications

Executive Order 12372 does not apply to this program.

 

IV.5. Funding restrictions

Restrictions, which applicants must take into account while writing the budget, are as follows:

  • Recipients may not use funds for research.

·        Needle Exchange - No funds appropriated under this Act shall be used to carry out any program of distributing sterile needles or syringes for the hypodermic injection of any illegal drug.

·        Recipients may spend funds for reasonable program purposes, including personnel, training, travel, supplies and services.  Recipients may purchase equipment and complete renovations if deemed necessary to accomplish program objectives, and if authorized by, and in accordance with, applicable federal law and HHS/CDC policy, and conduct procurements in a transparent and competitive manner.

·        Applicants shall state all requests for funds contained in the budget in U.S. dollars.  Once HHS/CDC makes an award, grantees will not be compensated for foreign currency-exchange fluctuations through the issuance of supplemental awards.

·        The costs generally allowable in grants to domestic organizations are allowable to foreign institutions and international organizations, with the following exception: With the exception of the American University, Beirut, and the World Health Organization, HHS/CDC will not pay indirect costs (either directly

or through sub-award) to organizations located outside the territorial limits of the United States or to international organizations, regardless of their location.

·        Recipients may contract with other organizations under this program; however, recipients must perform a substantial portion of the activities (including program management and operations, and delivery of prevention services for which funds are required) relating to the management of sub-grants to local organizations and improving their capacity, and must award any subcontracts through a competitive and transparent process.

·        Foreign recipients are subject to audit requirements specified in 45 CFR 74.26(d).  A non-Federal audit is required if, during the recipient’s fiscal year, the recipient expended a total of $500,000.00 or more under one or more HHS awards (as a direct recipient and/or as a sub-recipient).  The recipient either may have:  (1) a financial related audit (as defined in the Government Auditing Standards, GPO stock #020-000-00-265-4) of a particular award in accordance with Government Auditing Standards, in those cases where the recipient receives awards under only one HHS program; or, (2) an audit that meets the requirements contained in OMB Circular A-133.

·        A fiscal Recipient Capability Assessment may be required, prior to or post award, to review the applicant’s business management and fiscal capabilities regarding the handling of U.S. Federal funds.

 

Prostitution and Related Activities

 

The U.S. Government is opposed to prostitution and related activities, which are inherently harmful and dehumanizing, and contribute to the phenomenon of trafficking in persons. 

 

Any entity that receives, directly or indirectly, U.S. Government funds in connection with this document (“recipient”) cannot use such U.S. Government funds to promote or advocate the legalization or practice of prostitution or sex trafficking.  Nothing in the preceding sentence shall be construed to preclude the provision to individuals of palliative care, treatment, or post-exposure pharmaceutical prophylaxis, and necessary pharmaceuticals and commodities, including test kits, condoms, and, when proven effective, microbicides. 

 

A recipient that is otherwise eligible to receive funds in connection with this document to prevent, treat, or monitor HIV/AIDS shall not be required to endorse or utilize a multisectoral approach to combating HIV/AIDS, or to endorse, utilize, or participate in a prevention method or treatment program to which the recipient has a religious or moral objection.  Any information provided by recipients about the use of condoms as part of projects or activities that are funded in connection with this document shall be medically accurate and shall include the public health benefits and failure rates of such use.

 

In addition, any recipient must have a policy explicitly opposing prostitution and sex trafficking.  The preceding sentence shall not apply to any “exempt organizations” (defined as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Health Organization and its six Regional Offices, the International AIDS Vaccine Initiative or any United Nations agency).

 

The following definition applies for purposes of this clause:

·        Sex trafficking means the recruitment, harboring, transportation, provision, or obtaining of a person for the purpose of a commercial sex act.  22 U.S.C. § 7102(9).

 

All recipients must insert provisions implementing the applicable parts of this section, “Prostitution and Related Activities,” in all subagreements under this award.  These provisions must be express terms and conditions of the subagreement, must acknowledge that compliance with this section, “Prostitution and Related Activities,” is a prerequisite to receipt and expenditure of U.S. Government funds in connection with this document, and must acknowledge that any violation of the provisions shall be grounds for unilateral termination of the agreement prior to the end of its term.  Recipients must agree that HHS may, at any reasonable time, inspect the documents and materials maintained or prepared by the recipient in the usual course of its operations that relate to the organization’s compliance with this section, “Prostitution and Related Activities.”

 

All prime recipients that receive U.S. Government funds (“prime recipients”) in connection with this document must certify compliance prior to actual receipt of such funds in a written statement that makes reference to this document (e.g., “[Prime recipient's name] certifies compliance with the section, “Prostitution and Related Activities.”) addressed to the agency’s grants officer.  Such certifications by prime recipients are prerequisites to the payment of any U.S. Government funds in connection with this document. 

 

Recipients' compliance with this section, “Prostitution and Related Activities,” is an express term and condition of receiving U.S. Government funds in connection with this document, and any violation of it shall be grounds for unilateral termination by HHS of the agreement with HHS in connection with this document prior to the end of its term.  The recipient shall refund to HHS the entire amount furnished in connection with this document in the event HHS determines the recipient has not complied with this section, “Prostitution and Related Activities.”

 

The recommended guidance for completing a detailed justified budget can be found on the HHS/CDC Web site, at the following Internet address:

http://www.cdc.gov/od/pgo/funding/budgetguide.htm.  

IV.6. Other Submission Requirements

Application Submission Address:

 

Electronic Submission:

HHS/CDC strongly encourages applicants to submit applications electronically at www.Grants.gov.  The application package can be downloaded from www.Grants.gov.  Applicants are able to complete it off-line, and then upload and submit the application via the Grants.gov Web site.  E-mail submissions will not be accepted.  If technical difficulties are encountered in Grants.gov, customer service can be reached by e-mail at support@grants.gov, or by phone at 1-800-518-4726 (1-800-518-GRANTS).  The Customer Support Center is open from 7:00 a.m. to 9:00 p.m., Eastern Time, Monday through Friday. 

 

HHS/CDC recommends that submittal of an application to Grants.gov should be prior to the closing date to resolve any unanticipated difficulties prior to the deadline.  Applicants may also submit a back-up paper submission of the application.  Any such paper submission must be received in accordance with the requirements for timely submission detailed in Section IV.3. of the grant announcement. The paper submission must be clearly marked:  “BACK-UP FOR ELECTRONIC SUBMISSION.”  The paper submission must conform to all requirements for non-electronic submissions.  If both electronic and back-up paper submissions are received by the deadline, the electronic version will be considered as the official submission.

 

HHS/CDC strongly recommends applicants submit the grant application by using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel, etc.).  If an applicant does not have access to Microsoft Office products, a PDF file may be submitted.  Applicants must submit all application attachments using a PDF format when submitting via Grants.gov.  Directions for creating PDF files are available on the Grants.gov Web site.  Use of file formats other than Microsoft Office or PDF could make the file unreadable by staff.

 

OR

 

Paper Submission:

Applicants should submit the original and two hard copies of the application by mail or express delivery service to:

            Technical Information Management- PS08-811

            Procurement and Grants Office

            Centers for Disease Control and Prevention

            U.S. Department of Health and Human Services

2920 Brandywine Road, Mail Stop E-14

            Atlanta, GA 30341

 

V. Application Review Information

V.1. Criteria

Applicants are required to provide measures of effectiveness that will demonstrate the accomplishment of the various identified objectives of the cooperative agreement.  Measures of effectiveness must relate to the performance goals stated in the “Purpose” section of this announcement.  Measures must be objective and quantitative and must measure the intended outcome.  The measures of effectiveness must be submitted with the application and will be an element of evaluation.

 

Applications will be evaluated against the following criteria:

 

Ability to Carry Out the Proposal (20 points)

Does the applicant demonstrate local experience in the Democratic Republic of Congo and institutional capacity (both management and technical) to achieve the goals of the project with documented good-governance practices?  Does the applicant have the ability to coordinate and collaborate with existing Emergency Plan partners and other donors, including the Global Fund and other U.S. Government Departments and agencies involved in implementing the Emergency Plan, including the U.S. Agency for International Development?  Is there evidence of leadership support and evidence of current or past efforts to enhance HIV prevention?  Does the applicant have the capacity to reach rural and other underserved populations in the Democratic Republic of Congo?  Does the organization have the ability to target audiences that frequently fall outside the reach of the traditional media, and in local languages?  To what extent does the applicant provide letters of support?

 

Technical and Programmatic Approach (20 points)

Does the application include an overall design strategy, including measurable time lines, clear monitoring-and-evaluation procedures, and specific activities for meeting the proposed objectives?  Does the applicant display knowledge of the strategy, principles and goals of the President's Emergency Plan for AIDS Relief, and are the proposed activities consistent with and pertinent to that strategy and those principles and goals?  Does the applicant describe activities that are evidence-based, realistic, achievable, measurable and culturally appropriate to achieve the goals of the Emergency Plan?  Does the application propose to build on and complement the current national response in the Democratic Republic of Congo with evidence-based strategies designed to reach underserved populations and meet the goals of the Emergency Plan?  Does the application include reasonable estimates of outcome targets?  (For example, the numbers of sites to be supported, number of clients the program will reach in the Democratic Republic of Congo)

 

Capacity-Building (15 points)

Does the applicant have a proven track-record of building the capacity of indigenous organizations and individuals?  Does the applicant have relevant experience in using participatory methods and approaches, in project planning and implementation?  Does the applicant describe an adequate and measurable plan to progressively build the capacity of local organizations and of target beneficiaries to respond to the epidemic?  If not a local indigenous organization, does the applicant articulate a clear exit strategy, which will maximize the legacy of this project in the intervention communities?  Does the capacity-building plan clearly describe how it will contribute to (a) improved quality and geographic coverage of service delivery to achieve the "2, 7, 10" targets of the Emergency Plan, and (b) (if not a local indigenous organization) an evolving role of the prime beneficiary with transfer of critical technical and management competence to local organizations/sites in support of a decentralized response?

 

Monitoring and Evaluation (15 points)

Does the applicant demonstrate the local experience and capability to implement rigorous monitoring and evaluation of the project?  Does the applicant describe a system for reviewing and adjusting program activities based on monitoring information obtained by using innovative, participatory methods and standard approaches?  Does the plan include indicators developed for each program milestone, and incorporated into the financial and programmatic reports?  Are the indicators consistent with the Emergency Plan Indicator Guide?  Is the system able to generate financial and program reports to show disbursement of funds, and progress towards achieving the numerical objectives of the President's Emergency Plan?  Is the plan to measure outcomes of the intervention, and the manner in which they will be provided, adequate?  Is the monitoring-and-evaluation plan consistent with the principles of the "Three Ones?"  Applicants must define specific output and outcome indicators must be defined in the proposal, and must have realistic targets in line with the targets addressed in the Activities section of this announcement.

 

Understanding of the Problem (10 points)

Does the applicant demonstrate a clear and concise understanding of the current national HIV/AIDS response and the cultural and political context relevant to the programmatic areas targeted?  Does the applicant display an understanding of the Five-Year Strategy and goals of the President's Emergency Plan?  To what extent does the applicant justify the need for this program within the target community?

 

Personnel (10 points)

Does the organization employ staff fluent in local languages who will work on this project?  Are the staff roles clearly defined?  As described, will the staff be sufficient to meet the goals of the proposed project?  If not an indigenous organization, does the staff plan adequately involve local individuals and organizations?  Are staff involved in this project qualified to perform the tasks described?  Curricula vitae provided should include information that they are qualified in the following:  management of HIV/AIDS prevention activities, especially confidential, voluntary counseling and testing; and the development of capacity-building among and collaboration between Governmental and non-governmental partners.

 

Administration and Management (10 points)

Does the applicant provide a clear plan for the administration and management of the proposed activities, and to manage the resources of the program, prepare reports, monitor and evaluate activities, audit expenditures and produce collect and analyze performance data?  Is the management structure for the project sufficient to ensure speedy implementation of the project?  If appropriate, does the applicant have a proven track record in managing large laboratory budgets; running transparent and competitive procurement processes; supervising consultants and contractors; using subgrants or other systems of sharing resources with community-based organizations, faith-based organizations or smaller non-governmental organizations; and providing technical assistance in laboratory or pharmacy management?  The grantee must demonstrate an ability to submit quarterly reports in a timely manner to the HHS/CDC office.

 

Budget (Reviewed, but not scored)

Is the itemized budget for conducting the project, along with justification, reasonable and consistent with stated objectives and planned program activities?  Is the budget itemized, well-justified and consistent with the Five-Year Strategy (2003-2008) and goals of the President's Emergency Plan and Emergency Plan activities?  If applicable, are there reasonable costs per client reached for both year one and later years of the project?

 

V.2. Review and Selection Process

Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff, and for responsiveness jointly by the HHS Global AIDS Program and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process.  Applicants will be notified the application did not meet submission requirements.

 

An objective review panel will evaluate complete and responsive applications according to the criteria listed in the “V.1. Criteria” section above.  All persons who serve on the panel will be external to the U.S. Government Country Program Office in the Democratic Republic of Congo.   The panel may include both Federal and non-Federal participants. 

 

In addition, the following factors could affect the funding decision:

HHS/CDC will fund applications in order by the score and rank determined by the review panel.  HHS/CDC will provide justification for any decision to fund out of rank order. 

 

V.3. Anticipated Announcement Award Dates

The anticipated award date is September 30, 2008.

 

VI. Award Administration Information

VI.1. Award Notices

Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office.  The NoA shall be the only binding, authorizing document between the recipient and CDC.  The NoA will be signed by an authorized Grants Management Officer and emailed to the program director, and a hard copy mailed to the recipient fiscal officer identified in the application.

 

Unsuccessful applicants will receive notification of the results of the application review by mail.

 

VI.2. Administrative and National Policy Requirements

Successful applicants must comply with the administrative requirements outlined in 45 CFR Part 74 and Part 92 as Appropriate.  The following additional requirements apply to this project:

  • AR - 4             HIV/AIDS Confidentiality Provisions;    
  • AR - 6             Patient Care;     
  • AR - 9             Paperwork Reduction Act Requirements;           
  • AR - 10           Smoke-Free Workplace Requirements;               
  • AR - 12           Lobbying Restrictions;   
  • AR - 14           Accounting System Requirements;          
  • AR - 23           Compliance with 45 C.F.R. Part 87;      
  • AR - 24           Health Insurance Portability and Accountability Act Requirements; and;  
  • AR - 25           Release and Sharing of Data.     

Additional information on the requirements can be found on the CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/Addtl_Reqmnts.htm.

 

For more information on the Code of Federal Regulations, see the National Archives and Records Administration, at the following Internet address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html

 

Applicants must include an additional Certifications form from the PHS5161-1 application in the Grants.gov electronic submission only.  Applicants should refer to the following Internet address:

http://www.cdc.gov/od/pgo/funding/PHS5161-1-Certificates.pdf.  Once the applicant has filled out the form, it should be attached to the Grants.gov submission as an Other Attachments Form.

 

VI.3. Reporting Requirements

The applicant must provide HHS/CDC with an original, plus two hard copies, of the following reports:

1.      Interim progress report, due no less than 90 days before the end of the budget period.  The progress report will serve as the non-competing continuation application, and must contain the following elements:

a.       Activities and Objectives for the Current Budget Period;

b.      Financial Progress for the Current Budget Period;

c.       Proposed Activity and Objectives for the New Budget Period Program;

d.      Detailed Budget;

e.       Measures of Effectiveness, including progress against the numerical goals of the President's Emergency Plan for AIDS Relief for Democratic Republic of Congo; and

f.        Additional Requested Information;

2.      Annual progress report, due 90 days after the end of the budget period.  Reports should include progress against the numerical goals of the President's Emergency Plan for AIDS Relief for Democratic Republic of Congo;

3.      Financial status report, due no more than 90 days after the end of the budget period; and

4.      Final financial status and progress reports, due no more than 90 days after the end of the project period.

These reports must be submitted to the attention of the Grants Management Specialist listed in the “VII. Agency Contacts” section of this announcement.

 

VII. Agency Contacts

HHS/CDC encourages inquiries concerning this announcement.

For general questions, contact:

            Technical Information Management Section

            Procurement and Grants Office

            Centers for Disease Control and Prevention

            U.S. Department of Health and Human Services

            2920 Brandywine Road, Mail Stop E-14

            Atlanta, GA 30341

            Telephone: 770-488-2700

 

For program technical assistance, contact:

Dr. Leon Motingia, Project Officer

            Centers for Disease Control and Prevention

            U.S. Department of Health and Human Services

L’Ambassade Americaine, Ave des Aviateurs,

Kinshasa/Gombe, Democratic Republic of the Congo

Telephone: 243-81-225-5232

E-mail: lmotingia@cdcdrc.org

 

For financial, grants management, or budget assistance, contact:

Anella Higgins, Grants Management Specialist

            Procurement and Grants Office

            Centers for Disease Control and Prevention

            U.S. Department of Health and Human Services

            2920 Brandywine Road, Mail Stop K-75

            Atlanta, GA 30341

            Telephone: (770) 488-2710

            E-mail: Ahiggins@cdc.gov

 

VIII. Other Information

Other HHS/CDC funding opportunity announcements are available on the HHS/CDC Web site, Internet address: http://www.cdc.gov/od/pgo/funding/FOAs.htm, and on the web site of the HHS Office of Global Health Affairs, Internet address: www.globalhealth.gov.

 

 

CDC Home Page: http://www.cdc.gov

CDC Funding Web Page: http://www.cdc.gov/od/pgo/funding/FOAs.htm  

CDC Forms Web Page: http://www.cdc.gov/od/pgo/funding/grants/app_and_forms.shtm